IL163769A0 - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number
IL163769A0
IL163769A0 IL16376903A IL16376903A IL163769A0 IL 163769 A0 IL163769 A0 IL 163769A0 IL 16376903 A IL16376903 A IL 16376903A IL 16376903 A IL16376903 A IL 16376903A IL 163769 A0 IL163769 A0 IL 163769A0
Authority
IL
Israel
Prior art keywords
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
IL16376903A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL163769A0 publication Critical patent/IL163769A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/10Ophthalmic agents for accommodation disorders, e.g. myopia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL16376903A 2002-03-07 2003-03-06 Quinoline derivatives IL163769A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02005117 2002-03-07
EP02005115 2002-03-07
PCT/EP2003/002321 WO2003074511A1 (en) 2002-03-07 2003-03-06 Quinoline derivatives

Publications (1)

Publication Number Publication Date
IL163769A0 true IL163769A0 (en) 2005-12-18

Family

ID=27790094

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16376903A IL163769A0 (en) 2002-03-07 2003-03-06 Quinoline derivatives

Country Status (29)

Country Link
US (2) US7399768B2 (xx)
EP (1) EP1480970B1 (xx)
JP (2) JP2005519117A (xx)
KR (1) KR101027977B1 (xx)
CN (2) CN1939915A (xx)
AR (1) AR038730A1 (xx)
AU (1) AU2003219023B2 (xx)
BR (1) BR0308201A (xx)
CA (2) CA2477720C (xx)
CO (1) CO5611196A2 (xx)
CY (1) CY1106409T1 (xx)
DE (1) DE60311233T2 (xx)
DK (1) DK1480970T3 (xx)
EC (1) ECSP045271A (xx)
EG (1) EG24415A (xx)
ES (1) ES2279100T3 (xx)
HK (1) HK1071364A1 (xx)
IL (1) IL163769A0 (xx)
MX (1) MXPA04008666A (xx)
MY (1) MY134325A (xx)
NO (1) NO20044117L (xx)
NZ (1) NZ534732A (xx)
PE (1) PE20030927A1 (xx)
PL (2) PL215012B1 (xx)
PT (1) PT1480970E (xx)
RU (1) RU2345991C2 (xx)
SI (1) SI1480970T1 (xx)
TW (1) TW200406401A (xx)
WO (1) WO2003074511A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1757601B1 (en) * 2002-03-07 2009-08-05 Novartis AG Quinoline derivatives and their use in glaucoma and myopia
US10729710B2 (en) 2017-11-24 2020-08-04 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's disease
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
PE20030240A1 (es) * 2001-07-09 2003-04-16 Novartis Ag DERIVADOS DE BENZO [g] QUINOLINA

Also Published As

Publication number Publication date
HK1071364A1 (en) 2005-07-15
EP1480970B1 (en) 2007-01-17
ES2279100T3 (es) 2007-08-16
ECSP045271A (es) 2004-10-26
CN1639148A (zh) 2005-07-13
AU2003219023A1 (en) 2003-09-16
PT1480970E (pt) 2007-03-30
KR101027977B1 (ko) 2011-04-13
CN1939915A (zh) 2007-04-04
PL370915A1 (en) 2005-06-13
MXPA04008666A (es) 2004-12-06
US20080255176A1 (en) 2008-10-16
SI1480970T1 (sl) 2007-06-30
US7399768B2 (en) 2008-07-15
TW200406401A (en) 2004-05-01
AU2003219023B2 (en) 2006-11-30
PL210336B1 (pl) 2012-01-31
PL394208A1 (pl) 2011-08-16
BR0308201A (pt) 2005-01-04
DE60311233T2 (de) 2007-11-15
DK1480970T3 (da) 2007-03-05
CA2477720A1 (en) 2003-09-12
RU2345991C2 (ru) 2009-02-10
RU2004129767A (ru) 2005-06-27
US20050234085A1 (en) 2005-10-20
EP1480970A1 (en) 2004-12-01
JP2010095550A (ja) 2010-04-30
WO2003074511A1 (en) 2003-09-12
CA2706618A1 (en) 2003-09-12
PE20030927A1 (es) 2003-12-26
CA2477720C (en) 2010-09-21
JP2005519117A (ja) 2005-06-30
DE60311233D1 (de) 2007-03-08
EG24415A (en) 2009-05-25
PL215012B1 (pl) 2013-10-31
NO20044117L (no) 2004-09-28
KR20040089615A (ko) 2004-10-21
CO5611196A2 (es) 2006-02-28
CN1293070C (zh) 2007-01-03
CY1106409T1 (el) 2011-10-12
AR038730A1 (es) 2005-01-26
NZ534732A (en) 2006-05-26
MY134325A (en) 2007-12-31

Similar Documents

Publication Publication Date Title
IL164324A0 (en) Quinolinone derivatives
ZA200603657B (en) Novel quinoline derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
HK1077068A1 (en) Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) AZAARENE DERIVATIVES
PL376475A1 (en) N-substituted-2-oxodihydropyridine derivatives
ZA200500471B (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
HK1080836A1 (en) Isoquinoline derivatives
PL376997A1 (pl) Pochodne tetrahydrochinoliny
PL377318A1 (pl) Pochodne tetrahydrochinoliny
HK1071364A1 (en) Quinoline derivatives
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
GB0104422D0 (en) Quinoline derivative
PL371216A1 (en) Isoquinoline derivatives
AU2003274551A1 (en) Quinoline derivatives
EP1531854A4 (en) O-DERIVATED NOCATHIACIN DERIVATIVES
GB0213488D0 (en) 2-Naphthamide derivatives
AU2003243397A8 (en) Homo-camptothecin derivatives
HK1077577A1 (en) Tetrahydroquinoline derivatives
AU2003290095A8 (en) Quinolizidine derivatives
AU2003285777A8 (en) 3-substituted-4-pyrimidone derivatives
GB0221143D0 (en) Dihydropyridinone derivatives
GB0210512D0 (en) Tetrahydro-napthalene derivatives